
GLP-1 Drugs Are Treating Heart Disease, Kidney Failure, and Liver Disease — Weight Loss Was Just the Beginning
GLP-1 receptor agonists like semaglutide and tirzepatide are showing robust clinical benefits for cardiovascular disease, chronic kidney disease, and liver disease — benefits that appear independent of how much weight patients lose.










